These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12378549)

  • 1. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
    Kurtz KA; Schlueter AJ
    J Clin Apher; 2002; 17(3):135-7. PubMed ID: 12378549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
    Appel GB; Cook HT; Hageman G; Jennette JC; Kashgarian M; Kirschfink M; Lambris JD; Lanning L; Lutz HU; Meri S; Rose NR; Salant DJ; Sethi S; Smith RJ; Smoyer W; Tully HF; Tully SP; Walker P; Welsh M; Würzner R; Zipfel PF
    J Am Soc Nephrol; 2005 May; 16(5):1392-403. PubMed ID: 15800116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
    Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
    J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab.
    Pérez-Sáez MJ; Toledo K; Navarro MD; Lopez-Andreu M; Redondo MD; Ortega R; Pérez-Seoane C; Agüera ML; Rodríguez-Benot A; Aljama P
    Transplant Proc; 2011 Dec; 43(10):4005-9. PubMed ID: 22172889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC; West CD; Strife CF
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
    Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
    Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2018; 9():2329. PubMed ID: 30487789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF; Prada AL; Clardy CW; Jackson E; Forristal J
    J Pediatr; 1990 May; 116(5):S98-102. PubMed ID: 2329415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Lorenz EC; Sethi S; Leung N; Dispenzieri A; Fervenza FC; Cosio FG
    Kidney Int; 2010 Apr; 77(8):721-8. PubMed ID: 20130531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).
    Ohi H; Watanabe S; Fujita T; Yasugi T
    Clin Exp Immunol; 1992 Sep; 89(3):479-84. PubMed ID: 1516262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.